Artificial glycan receptor key to rapid test for Covid-19

A lateral flow device that uses an artificial glycan receptor is being readied to provide rapid point-of-care diagnosis of Covid-19.

The simple-to-use testing device has the potential to be used by frontline NHS staff allowing doctors and nurses to easily test at home to see if they have COVID-19 symptoms or not before going to work. Similarly, communities associated with a building or geographical location which require increased safeguarding - hospitals, care homes or workplaces - could quickly test visitors.

Testing times in Covid-19 response

More Covid-19 technology stories from The Enginer

Professor Rob Field is Co-founder and CEO of Norwich-based spin-out company Iceni Diagnostics, which is working with his team of biotech researchers at Manchester University on getting the new test ready and officially validated ready for autumn and the onset of flu season, a period in which people with flu can have similar symptoms to those with Covid-19.

In a statement, Prof Field said: “Our existing prototype product for influenza can detect the virus in less than 20 minutes and could be adapted to identify other pathogens such as coronavirus.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox